These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31043541)

  • 1. Are Target Urate and Remission Possible in Severe Gout? A Five-year Cohort Study.
    Alvarado-de la Barrera C; López-López CO; Álvarez-Hernández E; Peláez-Ballestas I; Gómez-Ruiz C; Burgos-Vargas R; Vázquez-Mellado J
    J Rheumatol; 2020 Jan; 47(1):132-139. PubMed ID: 31043541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Influencing the Effectiveness of Allopurinol in Achieving and Sustaining Target Serum Urate in a US Veterans Affairs Gout Cohort.
    Singh JA; Yang S; Saag KG
    J Rheumatol; 2020 Mar; 47(3):449-460. PubMed ID: 31416925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout.
    Dalbeth N; House ME; Horne A; Petrie KJ; McQueen FM; Taylor WJ
    BMC Musculoskelet Disord; 2012 Sep; 13():174. PubMed ID: 22978848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden and management of gout in a multi-ethnic Asian cohort.
    Chua CKT; Cheung PP; Santosa A; Lim AYN; Teng GG
    Rheumatol Int; 2020 Jul; 40(7):1029-1035. PubMed ID: 31758246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palpable tophi and more comorbidities associated with adherence to urate-lowering medical therapy in a Chinese gout cohort.
    Hu S; Terkeltaub R; Sun M; Ji X; Li Z; Ran Z; Li Y; Zhang H; Sun W; Li C; Lu J
    Joint Bone Spine; 2022 Nov; 89(6):105435. PubMed ID: 35777552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase.
    Mandell BF; Yeo AE; Lipsky PE
    Arthritis Res Ther; 2018 Dec; 20(1):286. PubMed ID: 30594229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study.
    Uhlig T; Karoliussen LF; Sexton J; Kvien TK; Haavardsholm EA; Perez-Ruiz F; Hammer HB
    Clin Rheumatol; 2022 Dec; 41(12):3817-3823. PubMed ID: 36316609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysis.
    Stamp L; Morillon MB; Taylor WJ; Dalbeth N; Singh JA; Lassere M; Christensen R
    Semin Arthritis Rheum; 2018 Oct; 48(2):293-301. PubMed ID: 29566967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form-36 is responsive to change in chronic gout.
    Khanna PP; Perez-Ruiz F; Maranian P; Khanna D
    Rheumatology (Oxford); 2011 Apr; 50(4):740-5. PubMed ID: 21147824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum urate during acute gout.
    Schlesinger N; Norquist JM; Watson DJ
    J Rheumatol; 2009 Jun; 36(6):1287-9. PubMed ID: 19369457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of Achieving Serum Urate Goal with Treat-to-Target Urate-Lowering Therapy in Gout.
    Helget LN; O'Dell JR; Newcomb JA; Androsenko M; Brophy MT; Davis-Karim A; England BR; Ferguson R; Pillinger MH; Neogi T; Palevsky PM; Wu H; Kramer B; Mikuls TR
    Arthritis Rheumatol; 2024 Apr; 76(4):638-646. PubMed ID: 37842953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The target uric acid level in multimorbid patients with gout is difficult to achieve: data from a longitudinal Swiss single-centre cohort.
    Ankli B; Berger CT; Haeni N; Kyburz D; Hügle T; So AK; Daikeler T
    Swiss Med Wkly; 2019 Aug; 149():w20121. PubMed ID: 31476243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with Gout Treated with Conventional Urate-lowering Therapy: Association with Disease Control, Health-related Quality of Life, and Work Productivity.
    Wood R; Fermer S; Ramachandran S; Baumgartner S; Morlock R
    J Rheumatol; 2016 Oct; 43(10):1897-1903. PubMed ID: 27036386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent validity of provisional remission criteria for gout: a dual-energy CT study.
    Dalbeth N; Frampton C; Fung M; Baumgartner S; Nicolaou S; Choi HK
    Arthritis Res Ther; 2019 Jun; 21(1):150. PubMed ID: 31227018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level.
    Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
    Clin Pharmacol Ther; 2011 Sep; 90(3):392-8. PubMed ID: 21796116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-stage approach to the treatment of hyperuricemia in gout: the "dirty dish" hypothesis.
    Perez-Ruiz F; Herrero-Beites AM; Carmona L
    Arthritis Rheum; 2011 Dec; 63(12):4002-6. PubMed ID: 21898351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving serum urate targets in gout: an audit in a gout-oriented rheumatology practice.
    Corbett EJM; Pentony P; McGill NW
    Int J Rheum Dis; 2017 Jul; 20(7):894-897. PubMed ID: 28205336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift.
    Khanna P; Khanna D; Storgard C; Baumgartner S; Morlock R
    Postgrad Med; 2016 Jan; 128(1):34-40. PubMed ID: 26578028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gouty tophus: a review.
    Chhana A; Dalbeth N
    Curr Rheumatol Rep; 2015 Mar; 17(3):19. PubMed ID: 25761926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of effect of tart cherry concentrate dose on serum urate in people with gout.
    Stamp LK; Chapman P; Frampton C; Duffull SB; Drake J; Zhang Y; Neogi T
    Rheumatology (Oxford); 2020 Sep; 59(9):2374-2380. PubMed ID: 31891407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.